stockrow
Friday 6 November 2026
Export OSTX’s income statement to Excel — free account
OS Therapies Incorporated
OSTX Healthcare Biotechnology
- EPS
- −5.26%
- Free cash flow
- −134.4%
Quarter to June 2026, against a year earlier
0.96
0.02
−2.04%
Follow OSTX
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 1,129.52% | 469.98% | 614.26% | (1,248.03%) |
+8 more TTM periods Free account |
|
| (389.65%) | (610.85%) | (464.58%) | (334.55%) | ||
ROIC |
0.00% | 0.00% | 0.00% | (434.52%) | |
Return on Tangible Assets |
231.59% | 220.00% | 251.58% | 1,004.35% | |
Average Days of Receivables |
0.00 | — | — | — | |
Free Cash Flow per Share |
(0.42) | (0.40) | (0.49) | (0.40) | |
Free Cash Flow |
(18.53) | (15.36) | (14.24) | (12.88) | |
| Other line items | |||||
Cash ROIC |
174.20% | 173.84% | 299.44% | (195.65%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
(71.46) | (26.09) | — | — | |
Operating CF/Net income |
0.47 | 0.44 | 0.50 | 0.70 | |
Depreciation/Fixed assets |
1,465.00 | 885.50 | 560.28 | 74.84 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.42) | (0.40) | (0.49) | (0.40) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 26 Oct 2026